Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Zeideman Pharmaceutical Technology

Request full access

Innovative small molecule drugs for immune-mediated diseases, addressing major clinical needs in CNS, respiratory, and skin conditions

ChinaFounded 2021Biotech & Life Sciences

About Shanghai Zeideman Pharmaceutical Technology

Thederma focuses on the research and development of innovative drugs targeting immune-mediated diseases, particularly in the fields of central nervous system (CNS), facial features, respiratory, and skin diseases. The company operates in the biopharmaceutical market, serving clinicians and patients with unmet clinical needs. Thederma's business model revolves around the discovery and development of small molecule drugs, leveraging a unique and highly differentiated product portfolio. The company generates revenue through the commercialization of these innovative drugs, aiming to provide better treatment options for clinicians and improve patient outcomes. The management team boasts extensive experience in drug R&D, technology, capital, and industry, ensuring efficient and rapid medical transformation and marketing of their products.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
20.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Oct 2024 $14M $55M Hankang Capital · Qingdao Guoxin Group ↗
SERIES A✓Equity / VC Mar 2023 $14M $55M Hankang Capital · Bainuo Capital · Betta Fund ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Zeideman Pharmaceutical Technology website traffic

Latest recorded traffic for Shanghai Zeideman Pharmaceutical Technology is 470 monthly website visits, up 62.1% over the last three months.

Latest monthly visits470 3-month web change+62.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Zeideman Pharmaceutical Technology in its local ecosystem

Live from Dealroom

The Shanghai Zeideman Pharmaceutical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Bainuo Capital
  • Hankang Capital
  • Betta Fund
  • Qingdao Guoxin Group
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Zeideman Pharmaceutical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Zeideman Pharmaceutical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.